Circassia shares sink after trial of cat allergy treatment
June 20, 2016 at 07:22 AM EDT
Circassia Pharma shares were more than halved Monday after a disappointing outcome of a study focusing on an experimental cat allergy treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.